Mutation-based diagnostic testing for primary hyperoxaluria type 1: Survey of results

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 598-602

  Coulter Mackie, Marion B ^a   Lian, Qun ^a   Applegarth, Derek A ^a   Toone, Jennifer ^a   Waters, Paula J ^a   Vallance, Hilary ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alanine:glyoxylate aminotransferase; Inborn errors of metabolism; Molecular diagnostic testing; Primary hyperoxaluria type 1

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA SEQUENCE; ENZYME ASSAY; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; OXALOSIS 1; PRIORITY JOURNAL;

BRITISH COLUMBIA; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; HEALTH SURVEYS; HUMANS; HYPEROXALURIA, PRIMARY; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; POLYMORPHISM, GENETIC;

EID: 41849114848     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.01.018     Document Type: Article

References (32)

1. Danpure C.J. Primary hyperoxaluria. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. (2001), McGraw-Hill, New York 3323-3367.
2. Coulter-Mackie M.B., White C., and Hurley R.M. Primary hyperoxaluria type 1. Gene reviews at gene tests; medical genetics information resource (database online) (1997-2007), Seattle, Copyright University of Washington. http://www.genetests.org Available at http://www.genetests.org. 2006
3. Danpure C.J., Jennings P.R., Fryer P., Purdue P.E., and Allsop J. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity. J Inher Metab Dis 17 (1994) 487-499
4. Purdue P.E., Lumb M.J., Fox M., et al. Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase. Genomics 10 (1991) 34-42.
5. Purdue P.E., Lumb M.J., Allsop J., and Danpure C.J. An intronic duplication in the alanine:glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygote patients with primary hyperoxaluria type 1. Hum Genet 87 (1991) 394-396
6. Lumb M.J., and Danpure C.J. Functional synergism between the most common polymorphism in human alanine: glyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem 275 (2000) 36415-36422
7. Danpure C.J., Birdsey G.M., Rumsby G., Lumb M.J., Purdue P.E., and Allsop J. Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene. Hum Genet 94 (1994) 55-64
8. Tarn A.C., Von Schnakenburg C., and Rumsby G. Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT). J Inher Metab Dis 20 (1997) 689-696
9. Coulter-Mackie M.B., Tung A., Henderson H.E., Toone J.R., and Applegarth D.A. The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in black Africans. Mol Genet Metab 78 (2003) 44-50
10. Coulter-Mackie M.B., and Rumsby G. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis. Mol Genet Metab 83 (2004) 38-46
11. Coulter-Mackie M., Lian Q., Applegarth D., and Toone J. The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1. Mol Genet Metab 86 (2005) 172-178
12. Monico C.G., Olson J., and Milliner D.S. Implications of genotype and enzyme phenotype in pyridoxine response of patients with type 1 primary hyperoxaluria. Am J Nephrol 25 (2005) 183-188
13. Yuen Y., Lai C., Tong G.M., et al. Novel mutations of the AGXT gene causing primary hyperoxaluria type 1. J Nephrol 17 (2004) 436-440
14. Williams E., and Rumsby G. Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. Clin Chem 53 (2007) 1216-1221
15. Monico C.G., Rossetti S., Schwanz H.A., et al. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol 18 (2007) 1905-1914
16. Rumsby G., Williams E., and Coulter-Mackie M. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 66 (2004) 959-963
17. Toone J.R., and Applegarth D.A. Micromethod for the assay of glutamate:glyoxylate aminotransferase and modifications of a micromethod for the assay of alanine:glyoxylate aminotransferase. Implications for the prenatal diagnosis of type 1 hyperoxaluria by fetal liver biopsy. Clin Chim Acta 203 (1991) 105-106
18. Coulter-Mackie M.B., Applegarth D., Toone J.R., and Henderson H. The major allele of the alanine:glyoxylate aminotransferase gene: seven novel mutations causing primary hyperoxaluria type 1. Mol Genet Metab 82 (2004) 64-68
19. von Schnakenburg C., and Rumsby G. Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene. J Med Genet 34 (1997) 489-492
20. Danpure C.J., Purdue P.E., Fryer P., et al. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mis-targeting and intraperoxisomal aggregation. Am J Hum Genet 53 (1993) 417-432
21. Pirulli D., Marangella M., and Amorosa A. Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol 16 2 (2003) 1-18
22. Pirulli D., Puzzer D., Ferri L., et al. Molecular analysis of hyperoxaluria type 1 in Italian patients reveals eight new mutations in the alanine:glyoxylate aminotransferase gene. Hum Genet 104 (1999) 523-525
23. Purdue P.E., Lumb M.J., Allsop J., Minatogawa Y., and Danpure C.J. A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1. Genomics 13 (1992) 215-218
24. Coulter-Mackie M.B., Rumsby G., Applegarth D.A., and Toone J.R. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria. Mol Genet Metab 74 (2001) 314-321
25. Amoroso A., Pirulli D., Puzzer D., et al. AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol 12 (2001) 2072-2079
26. Rinat C., Wanders R.J.A., Drukker A., Halle D., and Frishberg Y. Primary hyperoxaluria type: a model for multiple mutations in a monogenic disease within a distinct ethnic group. J Am Soc Nephrol 10 (1999) 2352-2358
27. Coulter-Mackie M.B. Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype. Am J Nephrol 25 (2005) 264-268
28. Santana A., Salido E., Torres A., and Shapiro L.J. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase. Proc Natl Acad Sci U S A 100 (2003) 7277-7282
29. Leumann E., and Hoppe G. Primary hyperoxaluria type 1: is genotyping clinically helpful?. Pediatr Nephrol 20 (2005) 555-557
30. Rumsby G. An overview of the role of genotypeing in the diagnosis of the primary hyperoxalurias. Urol Res 33 (2005) 318-320
31. Von Schnakenburg C., Rumsby G., Hoppe B., Latta K., and Kemper M. Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1. Pediatr Nephrol 18 (2003) 482-483
32. Milliner D.S. The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol (2005) 154-160